Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress

• मुख्य लेखकों: Anabel Torrente-López (लेखक), Jesús Hermosilla (लेखक), Antonio Salmerón-García (लेखक), José Cabeza (लेखक), Natalia Navas (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2022-03-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Nivolumab, formulated in the medicine Opdivo^® (10 mg/mL), is a therapeutic monoclonal antibody (mAb) used in the treatment of different types of cancer. Currently, there is insufficient knowledge about the behaviour of this protein with regards to the risk associated with its...